Clinical Trials: Anti-Dyskinesia Agents
- Amantadine 48 studies
- Antiparkinson Agents 1059 studies
- Apomorphine 21 studies
- Benserazide 6 studies
- Benztropine 8 studies
- Biperiden 4 studies
- Bromocriptine 15 studies
- Cabergoline 30 studies
- Carbidopa 95 studies
- Carbidopa, levodopa drug combination 44 studies
- Dexetimide 376 studies
- Droxidopa 19 studies
- Entacapone 34 studies
- Gabapentin 176 studies
- Levodopa 238 studies
- Lisuride 5 studies
- Memantine 130 studies
- Orphenadrine 1 study
- Piribedil 5 studies
- Pramipexol 89 studies
- Ropinirole 59 studies
- Selegiline 25 studies
- Tolcapone 8 studies
- Trihexyphenidyl 1 study
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/browse/intr_cat_AnDyAg
